62032-916-01 : NDC 2026 Code

62032-916-01 : Hydroquinone, Homosalate, Octisalate, Zinc Oxide ( Obagi-c C-rx System Normal-dry Skin Intervention )

Additionally :

You can get information about “62032-916-01” NDC code in 62032-916-01 in HTML format

HTML | 62032-916-01 in TXT (Plain Text) format

TXT | 62032-916-01 in PDF (Portable Document Format)

PDF | 62032-916-01 in XML format

XML formats.

NDC Code : 62032-916-01 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "62032-916-01",
    "PackageDescription": "1 KIT in 1 CARTON (62032-916-01)  *  1 TUBE in 1 CARTON (62032-140-09)  / 85 g in 1 TUBE *  177 mL in 1 BOTTLE, PLASTIC *  57 g in 1 BOTTLE, PLASTIC *  57 g in 1 BOTTLE, PLASTIC (62032-105-36)  *  1 BOTTLE, GLASS in 1 CARTON (62032-106-10)  / 30 mL in 1 BOTTLE, GLASS",
    "NDC11Code": "62032-0916-01",
    "ProductNDC": "62032-916",
    "ProductTypeName": "HUMAN OTC DRUG",
    "ProprietaryName": "Obagi-c C-rx System Normal-dry Skin Intervention",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Hydroquinone, Homosalate, Octisalate, Zinc Oxide",
    "DosageFormName": "KIT",
    "RouteName": null,
    "StartMarketingDate": "20191202",
    "EndMarketingDate": null,
    "MarketingCategoryName": "UNAPPROVED DRUG OTHER",
    "ApplicationNumber": null,
    "LabelerName": "Obagi Cosmeceuticals LLC",
    "SubstanceName": null,
    "StrengthNumber": null,
    "StrengthUnit": null,
    "Pharm_Classes": null,
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2026-01-28",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20271231",
    "StartMarketingDatePackage": "20210625",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}